Bertram Scott - Axa Equitable Independent Director
| EQH Stock | USD 48.08 0.23 0.48% |
Director
Mr. Bertram L. Scott is Independent Director of the company. Mr. Scott was a director since March 2019. Mr. Scott has served as Senior Vice President of population health of Novant Health, Inc. since February 2015. From November 2012 through December 2014, Mr. Scott served as President and Chief Executive Officer of Affinity Health Plan. From June 2010 to December 2011, Mr. Scott served as President, U.S. Commercial of CIGNA Corporationrationration. Prior thereto, he served as Executive Vice President of TIAACREF from 2000 to June 2010 and as President and Chief Executive Officer of TIAACREF Life Insurance Company from 2000 to 2007. Mr. Scott is currently a member of the Board of Directors of Becton, Dickinson and Company and Lowes Companies, Inc. Mr. Scott is also a director of MLOA since May 2012, and a director of AXA Equitable Life since March 2019. since 2019.
| Age | 69 |
| Tenure | 5 years |
| Address | 1345 Avenue Of The Americas, New York, NY, United States, 10105 |
| Phone | 212 554 1234 |
| Web | https://www.equitableholdings.com |
Bertram Scott Latest Insider Activity
Tracking and analyzing the buying and selling activities of Bertram Scott against Axa Equitable stock is an integral part of due diligence when investing in Axa Equitable. Bertram Scott insider activity provides valuable insight into whether Axa Equitable is net buyers or sellers over its current business cycle. Note, Axa Equitable insiders must abide by specific rules, including filing SEC forms every time they buy or sell Axa Equitable'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Bertram Scott over six months ago Disposition of 7000 shares by Bertram Scott of Axa Equitable at 35.2873 subject to Rule 16b-3 | ||
Bertram Scott over a year ago Acquisition by Bertram Scott of 6473 shares of Axa Equitable subject to Rule 16b-3 |
Axa Equitable Management Efficiency
The Axa Equitable's current Return On Tangible Assets is estimated to increase to 0.01. The Axa Equitable's current Return On Capital Employed is estimated to increase to 0.01. As of now, Axa Equitable's Return On Tangible Assets are increasing as compared to previous years. The Axa Equitable's current Intangibles To Total Assets is estimated to increase to 0.02, while Total Assets are projected to decrease to under 272.9 B. Axa Equitable's management efficiency ratios could be used to measure how well Axa Equitable manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Helen Hicks | Sun Life Financial | 60 | |
| Sara Lewis | Sun Life Financial | 52 | |
| Glenn Reed | Old Republic International | 68 | |
| Dawn Lai | Sun Life Financial | N/A | |
| James Peck | Sun Life Financial | 56 | |
| Martin Glynn | Sun Life Financial | 68 | |
| Margaret Harris | Sun Life Financial | 63 | |
| Henry Miller | American International Group | 73 | |
| Barbara Stymiest | Sun Life Financial | 64 | |
| James Cole | American International Group | 52 | |
| Peter McNitt | Old Republic International | 66 | |
| Arnold Steiner | Old Republic International | 83 | |
| Lisa Caldwell | Old Republic International | 60 | |
| Harrington Bischof | Old Republic International | 85 | |
| John Vollaro | Arch Capital Group | 79 | |
| John Fitzpatrick | American International Group | 63 | |
| John Dixon | Old Republic International | 81 | |
| William Jurgensen | American International Group | 69 | |
| Linda Mills | American International Group | 71 | |
| Jimmy Dew | Old Republic International | 79 | |
| Charles Kovaleski | Old Republic International | 72 | |
Management Performance
| Return On Equity | 0.0433 | ||||
| Return On Asset | 3.0E-4 |
Axa Equitable Holdings Leadership Team
Elected by the shareholders, the Axa Equitable's board of directors comprises two types of representatives: Axa Equitable inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Axa. The board's role is to monitor Axa Equitable's management team and ensure that shareholders' interests are well served. Axa Equitable's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Axa Equitable's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jessica Baehr, Head Retirement | ||
| Robin Raju, Senior Executive Vice President, Chief Financial Officer | ||
| George Stansfield, Non-Executive Director | ||
| Connie Weaver, Chief Marketing Officer | ||
| Bertram Scott, Independent Director | ||
| Anders Malmstrom, Senior Executive Vice President and Chief Financial Officer | ||
| William IV, Chief VP | ||
| Kristi Matus, Independent Director | ||
| Erik CFA, Head Relations | ||
| Daniel Kaye, Independent Director | ||
| Seth Bernstein, Senior Executive Vice President and Head of Investment Management and Research | ||
| Jeffrey Hurd, Senior Executive Vice President and Chief Operating Officer | ||
| Nicholas Lane, Senior Executive Vice President and Head of U.S. Life, Retirement and Wealth Management of EQH and President of AXA Equitable Life Insurance Company | ||
| Joan LammTennant, Chairman of the Board | ||
| Isil Muderrisoglu, Head Relations | ||
| Constance Weaver, Chief Officer | ||
| Charles Stonehill, Independent Director | ||
| Francis Hondal, Independent Director | ||
| Ramon Oliveira, Independent Chairman of the Board | ||
| Jeffrey JD, Senior COO | ||
| Stephanie Withers, Chief Auditor | ||
| Dave Hattem, Senior Executive Vice President, Chief Legal Officer, Secretary | ||
| Jose Gonzalez, Senior Executive Vice President, Chief Legal Officer, Company Secretary | ||
| Kermitt Brooks, Senior Executive Vice President | ||
| Mark Pearson, President, Chief Executive Officer, Director | ||
| Jose Esq, Chief EVP | ||
| Steven Joenk, Chief Officer | ||
| Yun Zhang, Chief Officer |
Axa Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Axa Equitable a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0433 | ||||
| Return On Asset | 3.0E-4 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 12.82 B | ||||
| Shares Outstanding | 313.34 M | ||||
| Shares Owned By Insiders | 0.47 % | ||||
| Shares Owned By Institutions | 97.78 % | ||||
| Number Of Shares Shorted | 4.13 M | ||||
| Price To Earning | 3.79 X |
Currently Active Assets on Macroaxis
When determining whether Axa Equitable Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axa Equitable's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axa Equitable Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axa Equitable Holdings Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Diversified Financial Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axa Equitable. If investors know Axa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axa Equitable listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Dividend Share 0.22 | Earnings Share (0.91) | Revenue Per Share 32.942 | Quarterly Revenue Growth (0.25) |
The market value of Axa Equitable Holdings is measured differently than its book value, which is the value of Axa that is recorded on the company's balance sheet. Investors also form their own opinion of Axa Equitable's value that differs from its market value or its book value, called intrinsic value, which is Axa Equitable's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axa Equitable's market value can be influenced by many factors that don't directly affect Axa Equitable's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axa Equitable's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axa Equitable is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axa Equitable's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.